These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 7604072)

  • 1. Lymphatic delivery of niosome encapsulated methotrexate.
    Jain CP; Vyas SP
    Pharmazie; 1995 May; 50(5):367-8. PubMed ID: 7604072
    [No Abstract]   [Full Text] [Related]  

  • 2. Engineered chylomicron mimicking carrier emulsome for lymph targeted oral delivery of methotrexate.
    Paliwal R; Paliwal SR; Mishra N; Mehta A; Vyas SP
    Int J Pharm; 2009 Oct; 380(1-2):181-8. PubMed ID: 19576973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug delivery to the lymphatic system.
    Porter CJ
    Crit Rev Ther Drug Carrier Syst; 1997; 14(4):333-93. PubMed ID: 9450175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A lymphotropic colloidal carrier system for diethylcarbamazine: preparation and performance evaluation.
    Karajgi JS; Vyas SP
    J Microencapsul; 1994; 11(5):539-45. PubMed ID: 7815271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of iontophoresis and soluble microneedles for transdermal delivery of methotrexate.
    Vemulapalli V; Yang Y; Friden PM; Banga AK
    J Pharm Pharmacol; 2008 Jan; 60(1):27-33. PubMed ID: 18088502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted delivery of methotrexate to skeletal muscular tissue by thermosensitive magnetoliposomes.
    Zhu L; Huo Z; Wang L; Tong X; Xiao Y; Ni K
    Int J Pharm; 2009 Mar; 370(1-2):136-43. PubMed ID: 19114095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles.
    Gao K; Jiang X
    Int J Pharm; 2006 Mar; 310(1-2):213-9. PubMed ID: 16426779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slow release properties and liver-targeting characteristics of methotrexate erythrocyte carriers.
    Yuan SH; Ge WH; Huo J; Wang XH
    Fundam Clin Pharmacol; 2009 Apr; 23(2):189-96. PubMed ID: 19298236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled delivery of methotrexate from channel-protein containing liposomes.
    van Deemter M; Smisterová J; van der Schaaf G; Meijberg W; Robillard G
    J Control Release; 2005 Jan; 101(1-3):342-3. PubMed ID: 15751183
    [No Abstract]   [Full Text] [Related]  

  • 10. Liposomes for drug targeting in the lymphatic system.
    Hirnle P
    Hybridoma; 1997 Feb; 16(1):127-32. PubMed ID: 9085139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot study of topical delivery of methotrexate by electroporation.
    Wong TW; Zhao YL; Sen A; Hui SW
    Br J Dermatol; 2005 Mar; 152(3):524-30. PubMed ID: 15787822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal lymphatic transport of halofantrine in rats assessed using a chylomicron flow blocking approach: the influence of polysorbate 60 and 80.
    Lind ML; Jacobsen J; Holm R; Müllertz A
    Eur J Pharm Sci; 2008 Oct; 35(3):211-8. PubMed ID: 18675904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of two glycerolipidic prodrugs of didanosine for direct lymphatic delivery against HIV.
    Lalanne M; Paci A; Andrieux K; Dereuddre-Bosquet N; Clayette P; Deroussent A; Ré M; Vassal G; Couvreur P; Desmaële D
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2237-40. PubMed ID: 17276686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative studies of different carriers and introducing routes on the effects of liver targeted uptake of exogenous gene].
    Yang C; Wang J; Wen S; Liu J; Guo J
    Zhonghua Gan Zang Bing Za Zhi; 2000 Aug; 8(4):227-9. PubMed ID: 10951625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo methotrexate disposition in alveolar macrophages: comparison of pharmacokinetic parameters of two formulations.
    Doddoli C; Ghez O; Barlési F; D'journo B; Robitail S; Thomas P; Clerc T
    Int J Pharm; 2005 Jun; 297(1-2):180-9. PubMed ID: 15869851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate delivery to the eye using transscleral hydrogel iontophoresis.
    Eljarrat-Binstock E; Domb AJ; Orucov F; Frucht-Pery J; Pe'er J
    Curr Eye Res; 2007; 32(7-8):639-46. PubMed ID: 17852187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro sustained human transscleral drug delivery of fluorescein-labeled dexamethasone and methotrexate with fibrin sealant.
    Cruysberg LP; Nuijts RM; Gilbert JA; Geroski DH; Hendrikse F; Edelhauser HF
    Curr Eye Res; 2005 Aug; 30(8):653-60. PubMed ID: 16109645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A significant methotrexate-glutamine pharmacokinetic interaction.
    Charland SL; Bartlett DL; Torosian MH
    Nutrition; 1995; 11(2):154-8. PubMed ID: 7647480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes.
    Metselaar JM; Wauben MH; Wagenaar-Hilbers JP; Boerman OC; Storm G
    Arthritis Rheum; 2003 Jul; 48(7):2059-66. PubMed ID: 12847701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel trans-lymphatic drug delivery system: implantable gelatin sponge impregnated with PLGA-paclitaxel microspheres.
    Liu J; Meisner D; Kwong E; Wu XY; Johnston MR
    Biomaterials; 2007 Jul; 28(21):3236-44. PubMed ID: 17434581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.